StocksFin Logo
Danaher Corporation
Danaher Corporation country of incorporation
|
https://www.danaher.com
|
Mr. Thomas Joyce
|
78,000 employees
NYSE | Healthcare | Diagnostics & Research
Abbott Laboratories
Abbott Laboratories country of incorporation
|
https://www.abbott.com
|
Mr. Robert Ford
|
113,000 employees
NYSE | Healthcare | Medical Devices
Q322 reported Oct 20, 2022 Reporting Period
$7.66B 6% vs. Q321 Revenues Q322
59.82% -0.8% vs. Q321 Gross Profit Margin
20.51% 28.1% vs. Q321 Net Profit Margin
1.73B -14.8% vs. Q321 Free Cash Flow Q322
$2.13 36.5% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.41%
Q322
0.68%
Q322 reported Nov 1, 2022 Reporting Period
$10.41B -4.7% vs. Q321 Revenues Q322
55.53% -6.7% vs. Q321 Gross Profit Margin
13.78% -28.3% vs. Q321 Net Profit Margin
2.31B -14.4% vs. Q321 Free Cash Flow Q322
$1.15 -3.2% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.41%
Q322
0.68%
Ratios
As of
Dec 31, 2022
Sep 30, 2022
Quick Ratio
1.3
1.22
Current Ratio
1.89
1.86
Cash Ratio
0.71
0.72
Price to Book
3.95
3.38
Price to Sales
6.29
11.6
Price to Earnings
27.87
21.03